HomeBVS • NASDAQ
Bioventus Inc
Follow
$8.33
8.96%
After Hours:(0.00%)0.00
$8.33
Closed: Apr 4, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 153.64M | 13.45% |
Operating expense | 91.55M | 9.35% |
Net income | -156.00K | 97.44% |
Net profit margin | -0.10 | 97.78% |
Earnings per share | 0.15 | 114.29% |
EBITDA | 15.90M | 71.18% |
Effective tax rate | 237.07% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 41.58M | 12.49% |
Total assets | 727.96M | -10.23% |
Total liabilities | 542.35M | -8.04% |
Total equity | 185.60M | — |
Shares outstanding | 66.16M | — |
Price to book | 4.07 | — |
Return on assets | 3.71% | — |
Return on capital | 4.90% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -156.00K | 97.44% |
Cash from operations | 19.32M | 86.25% |
Cash from investing | 24.10M | 4,178.51% |
Cash from financing | -42.86M | -306,007.14% |
Net change in cash | -1.49M | -114.72% |
Free cash flow | 21.76M | 228.77% |
Previous close
$9.15
Day range
$8.16 - $8.92
Year range
$3.90 - $14.37
Market cap
682.59M USD
Avg Volume
369.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Website
Employees
930